TSY-0110 - Kadcyla (T-DM1) Biosimilar
Model: TSY-0110
Category: Biosimilars
Exhibitor: FORMOSA PHARMACEUTICALS , INC
Booth No: M306
Characteristic
√ TSY-0110 is a biosimilar of ado-trastuzumab emtansine (Kadcyla®), the first-in-class ADC for HER2+ early breast cancer (EBC) and metastatistic breast cancer (MBC).
√ TSY-0110 is in late-preclinical development stages, planning for CTA filing and conduct phase I trial in 2024.
√ Formosa Pharmaceuticals is seeking interested parties for regional/global licensing or co-development.
Other Products
-
APP13007 - Clobetasol Propionate Ophthalmic Suspension 0.05% for the treatment of post-operative inflammation and pain following ocular surgery
-
APNT Nanoparticle Formulation Platform
-
APP13002 - Infectious Eye Diseases Treatment
Products you may be interested in
Highest Rated Products
-
2ton Mixing and Melting Tank with Storage Tanks
-
Planetary Vacuum Mixer
-
VACUUM EMULSIFY MIXING EQUIPMENT
-
Pneumatic Liquid Filling Machine
-
High Speed Mixing Machine
-
Powder Machine-High Speed Mixer / Granulator
-
VACUUM EMULSIFY MIXING EQUIPMENT (Bottom Homogenized Series)
-
SEMI-AUTOMATIC EYESHADOW PRESS MACHINE
-
In-Line Homogenizer
-
VACUUM EMULSIFY MIXING EQUIPMENT
-
Steel Basket-Strainer 20µm
-
NK Induction and Expansion Kit
-
PuraLev® SU Low Shear Single-Use Pump Systems
-
ABCcolla® Collagen Bone Graft
-
SOL Count, Lens-free automatic cell counter
-
CDMO
-
Cellabsys - SONICSTEM™ Non-contact Ultrasound device for Tissue Sonication
-
Exodus, Automatic exosome isolation system
-
GMP GLP GDP Life Science Engineering Services
-
WEARABLE STIMULATION DEVICE FOR STIMULATING DEEP MUSCLES OF ABDOMEN AND WAIST OF HUMAN BODY
-
EphA10-Trispecific Antibody of T & NK cell Engager
-
BLOOMNEST™ -Sialic acid
-
Prof. Ting-Wei Wang -- Wearable Pocket-Sized Fully Non-Contact Cardiorespiratory Sensor
-
EDA Low Laser Therapy Devices
-
Cell & Gene and Exosome therapy CDMO
-
ÜberStrainer 1 µm
-
ÜberStrainer 5µm
-
ÜberStrainer 10µm
-
ÜberStrainer 15µm
-
ÜberStrainer 20µm
